Mechanisms of antibody immunotherapy on clonal islet reactive T cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Human Immunology

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.HUMIMM.2006.02.027PMID 16720206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody dependent cellular cytotoxicity mediated by HLA-class II specific monoclonal antibodies.

  2008cited by this paper
• Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

  2005cited by this paper
• Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report

  2004cited by this paper
• PROSPECTIVE, RANDOMIZED TRIAL OF THE EFFECT OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION: THREE-YEAR RESULTS1

  2004cited by this paper
• Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice

  2004cited by this paper
• Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.

  2004cited by this paper
• Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials

  2003cited by this paper
• CD3-specific antibody-induced active tolerance: from bench to bedside

  2003cited by this paper
• Differential effects of interleukin-2 blockade on apoptosis in naïve and activated human lymphocytes12

  2003cited by this paper
• Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti‐CD25 monoclonal antibodies

  2003cited by this paper
• TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

  2003cited by this paper
• The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure

  2003cited by this paper
• Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).

  2002cited by this paper
• Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

  2002cited by this paper
• Thymoglobulin induction decreases rejection in solitary pancreas transplantation.

  2001cited by this paper
• Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase

  2001cited by this paper
• Determination of the frequency of HLA antibody secreting B‐lymphocytes in alloantigen sensitized individuals

  2001cited by this paper
• Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

  2000cited by this paper
• Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection.

  1999cited by this paper
• Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.

  1999cited by this paper
• Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.

  1999cited by this paper
• Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

  1999cited by this paper
• Anti-interleukin-2 receptor monoclonal antibodies in renal transplantation.

  1999cited by this paper
• Depleting effect of antithymocyte globulin on T-lymphocyte subsets in kidney transplantation.

  1999cited by this paper
• GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.

  1999cited by this paper
• Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac

  1998cited by this paper
• Interleukin-2-Receptor Blockade With Daclizumab to Prevent Acute Rejection in Renal Transplantation

  1998cited by this paper
• Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins.

  1998cited by this paper
• The use of antibodies against the IL-2 receptor in transplantation.

  1998cited by this paper
• Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

  1998cited by this paper
• T-Cell Reactivity to β-Cell Membrane Antigens Associated With β-Cell Destruction in IDDM

  1995cited by this paper
• T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM.

  1995cited by this paper
• THE EFFECT OF AGLYCOSYLATION ON THE IMMUNOGENICITY OF A HUMANIZED THERAPEUTIC CD3 MONOCLONAL ANTIBODY

  1995cited by this paper
• Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

  1994cited by this paper
• The generation of a humanized, non‐mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

  1993cited by this paper
• Prevention of Autoimmune Diabetes With Nonactivating Anti-CD3 Monoclonal Antibody

  1992cited by this paper
• Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

  1990cited by this paper
• T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins

  1990cited by this paper
• Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

  1989cited by this paper
• Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.

  1988cited by this paper
• Factors associated with early remission of type I diabetes in children treated with cyclosporine.

  1988cited by this paper
• Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.

  1985cited by this paper
• Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes.

  1979cited by this paper
• Microdroplet Assay of Human Serum Cytotoxins

  1964cited by this paper
• Spontaneous diabetes mellitus.

  1960cited by this paper

• Batch-to-Batch Variation and Patient Heterogeneity in Thymoglobulin Binding and Specificity: One Size Does Not Fit All

  2025cites this paper
• The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes

  2023cites this paper
• Immunosuppressive drugs and associated complications in abdominal organ transplantation

  2022cites this paper
• Combination of double negative T cells and anti-thymocyte serum reverses type 1 diabetes in NOD mice

  2016cites this paper
• T cells in the control of organ-specific autoimmunity.

  2015cites this paper
• Current Pathways for Immune Manipulation

  2014cites this paper
• Manipulating T cell-mediated pathology: targets and functions of monoclonal antibody immunotherapy.

  2013cites this paper
• CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients

  2012cites this paper
• Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice

  2012cites this paper
• Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.

  2012cites this paper
• Immunomodulating therapy in liver transplantation: principles and practice.

  2012cites this paper
• Rech in Concert with Immunotherapy in Cancer Patients CD 25 Blockade Depletes and Selectively Reprograms Regulatory T Cells

  2012cites this paper
• Preservation of recall immunity in anti‐CD3‐treated recent onset type 1 diabetes patients

  2011cites this paper
• Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

  2010cites this paper
• Antibodies to watch in 2010

  2010cites this paper
• Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go?

  2010cites this paper
• Short‐term anti‐CD25 monoclonal antibody administration down‐regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation

  2009cites this paper
• Treatment of Autoimmune Disease with Rabbit Anti‐T Lymphocyte Globulin

  2007cites this paper
• Strategies to treat autoimmune diabetes

  2007cites this paper
• Following Anti‐CD25 Treatment, A Functional CD4+CD25+ Regulatory T‐Cell Pool Is Present in Renal Transplant Recipients

  2007cites this paper
• Bibliography. Current world literature. Myositis and myopathies.

  2007cites this paper
• Current World Literature

  2007cites this paper